Partners Investment

Dime Bio is a drug development company for novel dementia treatments.

Arbor Biotechnologies, Inc., founded in 2016 and headquartered in Cambridge, Massachusetts, operates as a bio-discovery company in the biotechnology sector. The company focuses on developing genomic tools that enhance human health and sustainability. Utilizing a combination of artificial intelligence, genome sequencing, gene synthesis, and high-throughput screening, Arbor's platform accelerates the discovery of proteins and facilitates human diagnostic development. The technology aggregates genomic sequence data through AI and machine learning, enabling drug developers to replace entire genes and precisely correct mutations. This approach aims to streamline the development of curative treatments for previously incurable genetic diseases, ultimately improving the lives of patients affected by such conditions.

MediThinQ is a medical technology company focused on enhancing surgical procedures through its innovative eyes-up surgical display. The company designs and manufactures advanced medical glasses that provide surgeons with a comfortable and ergonomic viewing experience during complex surgeries. By prioritizing usability and functionality, MediThinQ aims to improve the surgical process, allowing for better visibility and ease of movement for medical professionals.

JLT supplies industrial automation equipment solutions and focuses on technology improvement through an integrated welding solution development project.

Sizzle is a company that provides an integrated process analysis solution based on accumulated experience.

Aigen Sciences is an artificial intelligence-driven drug discovery platform that focuses on the research and development of high-potency pharmaceuticals. The company employs advanced AI technology to discover drugs that effectively induce targeted cellular activity while minimizing off-target effects and toxicity. By streamlining the drug discovery process, Aigen Sciences enables clients to obtain effective medications rapidly and at a reduced cost. Its innovative approach aims to enhance the efficiency and effectiveness of drug development, positioning the company as a key player in the pharmaceutical industry.

StoreLink operates as an optimization platform for online marketplaces. It leverages AI-driven tools and accurate sales data analysis to enhance product visibility and improve sales forecasts, thereby boosting revenues for its client sellers.

Xpanner is a developer of a cloud-based construction management platform that integrates various construction technology products into a single solution. By streamlining disparate tools, Xpanner enables construction teams to access and manage data from one point, fostering collaboration among all stakeholders. This approach not only enhances productivity, with an average improvement of 15%, but also boosts management efficiency and safety on construction sites. Additionally, Xpanner's platform emphasizes environmental, social, and governance (ESG) improvements, making it a comprehensive solution for modern construction challenges.

Dewcell Biotherapeutics is a biotechnology company focused on the development of synthetic platelets through innovative biomimetic technology. The company utilizes human-derived stem cell-induced differentiation to transform stem cells into megakaryocytes, which are responsible for generating platelets. By mass-producing these artificial platelets, Dewcell Biotherapeutics aims to address the critical shortage of blood-derived platelets, offering a potential solution for medical applications where platelet availability is essential.

Dalpha specializes in developing customized B2B artificial intelligence solutions tailored for enterprises. The company focuses on maximizing revenue and minimizing costs by addressing specific business challenges through its advanced AI models. Dalpha emphasizes data security and ownership, ensuring that client information is protected within a secure cloud environment utilizing differential privacy technology. This approach enables organizations to access fast and accurate information while safeguarding sensitive data.

Artblood is a biotechnology company specializing in the production of artificial blood using cell-based technology. Its core product is a cell-based in vitro blood production system, designed to address the challenges associated with traditional blood transfusions. The company's platform generates reagent red blood cells for detecting transfusion-related antibodies and therapeutic red blood cells that can transport and express various therapeutic agents and immunostimulants. This innovative approach aims to provide patients with a safer and more efficient blood transfusion option, with fewer potential side effects.

Surginex is a biological drug development company focused on creating next-generation drug platforms and innovative therapeutics. It provides a comprehensive range of services, including molecular biology, genetics, and both physical and chemical analyses. Surginex employs advanced technologies, including artificial intelligence, to facilitate drug discovery and development. The company is involved in various stages of the drug development process, from conducting molecular biology experiments and animal studies to managing clinical trials. By integrating these capabilities, Surginex aims to expedite the recovery of patients through the development of novel drugs.

Soft Berry is an electric vehicle charging platform.

DYNE Medical Group is a medical equipment manufacturer specializing in endoscopy devices and artificial intelligence solutions for urological surgery. The company focuses on developing innovative manufacturing technologies that incorporate reusable flexible endoscopes, utilizing a unique optimization design and ultra-precision processing. This advanced approach aims to enhance the effectiveness of endoscopic procedures, facilitating minimally invasive treatments for patients. Additionally, DYNE Medical Group is committed to providing AI-based cancer diagnostics, further supporting healthcare professionals in delivering improved patient care.

Cytonus Therapeutics, Inc. is a biotechnology company founded in 2018 and located in Columbus, Ohio. The company specializes in developing immune-oncology and gene therapies aimed at addressing devastating and rare diseases. Cytonus employs a synthetic biology approach through its proprietary Cargocyte technology, which enables precision delivery of therapeutics and in vivo production of innovative treatments. By integrating AI-driven drug discovery methods, Cytonus is focused on creating first-in-class therapeutics to treat immune-related disorders effectively.

Quad Miners is a cybersecurity software developer focused on addressing security threats and enhancing internet security. The company employs a machine learning-based artificial intelligence analysis engine that enables the storage of network traffic without data loss while effectively detecting threats and anomalies. By leveraging this advanced technology, Quad Miners provides customers with reliable solutions to safeguard their data against malware attacks, ensuring easy and accurate cyber defense.

Harbinger Health is a biotechnology company focused on the early detection of cancer through an innovative blood testing model. By integrating artificial intelligence and machine learning with biological insights, Harbinger Health aims to identify cancer at an early stage, even before symptoms become apparent. The company's approach is designed to facilitate low-cost, multi-cancer blood tests, which could significantly enhance diagnostic capabilities in healthcare. Through its advanced technology, Harbinger Health seeks to improve cancer outcomes by enabling timely intervention and diagnosis.

BONABANK is an ERP software development company.

EndoRobotics is a healthcare company focused on advancing endoscopic surgery through the development of specialized robotic technology. The firm is creating an endoscopic surgery assist robot along with various surgical instruments aimed at enhancing treatment capabilities in the healthcare sector. By integrating robotics into therapeutic endoscopy, EndoRobotics seeks to improve the precision and effectiveness of minimally invasive surgical procedures, ultimately benefiting both healthcare providers and patients.

IMBiologics is a biotechnology company focused on developing innovative immunomodulatory antibody drugs aimed at restoring physiological balance. The company specializes in creating novel treatment options for autoimmune diseases and cancer. Its offerings include antibody-based immune modulating biologics that leverage advanced mechanisms of action to modulate the immune system. By utilizing modern biotechnological techniques, IMBiologics enables new approaches to cancer treatment, positioning itself as a key player in the field of immunotherapy.

AltPep Corp is a biomedical startup that specializes in diagnosing and treating amyloid diseases, which are known for their complexity and difficulty in management. The company has developed a proprietary peptide-based platform designed to diagnose and neutralize toxic precursors associated with these diseases. This innovative approach includes diagnostic, therapeutic, and anti-biofilm applications, particularly aimed at the early detection of toxic oligomers in Alzheimer's disease through a soluble oligomer binding assay. By focusing on early detection and effective treatment strategies, AltPep aims to enhance healthcare outcomes related to amyloid diseases, ultimately improving human health.

K-NETZ is an IT company that provides value-oriented R&D and possesses global technological competitiveness services.

Adcentrx Therapeutics is a biotechnology company dedicated to advancing protein conjugate therapeutics aimed at treating cancer and other life-threatening diseases. The company focuses on developing next-generation targeted therapies that leverage the precision of biologics combined with the efficacy of small molecule payloads. Through its innovative approach, Adcentrx aims to enhance treatment options for patients, providing them with more effective and targeted therapeutic solutions.

Ring Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative gene therapies utilizing its proprietary Anellovector platform. This platform, based on the human commensal virome, addresses several limitations of existing gene therapies, including restricted access to diverse tissues, challenges in redosing, risks of genomic integration, and issues with tolerability. Founded in 2017 and previously known as VL46, Inc., Ring Therapeutics aims to expand the applications of gene therapy beyond traditional gene replacement. By enabling a broader range of therapeutic modalities and mechanisms, the company seeks to treat a variety of previously inaccessible diseases, including genetic disorders, ophthalmology, oncology, and metabolic conditions.

Cytonus Therapeutics, Inc. is a biotechnology company founded in 2018 and located in Columbus, Ohio. The company specializes in developing immune-oncology and gene therapies aimed at addressing devastating and rare diseases. Cytonus employs a synthetic biology approach through its proprietary Cargocyte technology, which enables precision delivery of therapeutics and in vivo production of innovative treatments. By integrating AI-driven drug discovery methods, Cytonus is focused on creating first-in-class therapeutics to treat immune-related disorders effectively.

Upstairs is an online platform or B2B marketplace for customers to buy or sell previously used and owned mobile phones.

LBox is a developer of a platform designed to simplify online legal information lookup. Its digital platform functions as a search engine, allowing legal professionals to efficiently access and analyze case law, legal papers, and publications for case-related information.

Sonde Health is a digital medicine company focused on developing voice-based technologies for monitoring and diagnosing mental and respiratory health. The company's innovative platform utilizes mobile devices to capture and analyze subtle changes in voice, allowing for the creation of various health measurements related to brain, muscle, and respiratory function. By enabling users to track changes in their health over time, Sonde Health aims to identify early signs of disease, ultimately transforming the approach to health monitoring and diagnosis.

Mustbio is a biotechnology company founded in 2021 and based in Seoul, South Korea, specializing in the development of therapeutics for cancer treatment. The company utilizes a unique multi-antibody platform technology that mimics a natural-like asymmetric IgG form. This innovative approach facilitates a high rate of double antibody formation, enhancing the economic feasibility of its drug development. Mustbio focuses primarily on immuno-oncology, aiming to provide effective treatment options for patients facing various types of cancer.

Aigen Sciences is an artificial intelligence-driven drug discovery platform that focuses on the research and development of high-potency pharmaceuticals. The company employs advanced AI technology to discover drugs that effectively induce targeted cellular activity while minimizing off-target effects and toxicity. By streamlining the drug discovery process, Aigen Sciences enables clients to obtain effective medications rapidly and at a reduced cost. Its innovative approach aims to enhance the efficiency and effectiveness of drug development, positioning the company as a key player in the pharmaceutical industry.

Founded in 2015, SentBe is a global financial technology company that provides innovative remittance and payment solutions for individuals and businesses. With a mission to create "A World Without Financial Borders," SentBe facilitates seamless international money transfers through its advanced online platform. The company specializes in non-cent transfers, leveraging price differences between Bitcoin exchanges across various countries to optimize the remittance process. By establishing extensive global partnerships and enhancing foreign exchange management capabilities, SentBe delivers competitive cross-border payment solutions that benefit its clients in both domestic and international markets. Through its commitment to borderless financial services, SentBe is positioning itself as a leader in the global remittance industry.

Sharetreats Innovation is a company based in Makati, Philippines, that has developed a platform enabling consumers to send and receive vouchers redeemable at select nearby branches. After a payment is completed, treat codes are delivered via SMS, facilitating a seamless gifting experience. In addition to its voucher system, Sharetreats promotes a cultural movement encouraging social interactions through casual gifts, offering a variety of stickers and greetings suitable for various events.

Senda Biosciences, founded in 2017 by David Kolesky, Ignacio Martinez, and John Casey in Cambridge, Massachusetts, focuses on developing therapeutic applications for innovative treatments of human diseases. The company specializes in studying the molecular relationships between bacterial, botanical, and human cells to understand how these interactions influence health and disease. By gaining insights into these interspecies connections, Senda Biosciences aims to create novel categories of medicines and delivery methods, providing medical professionals with new tools to combat various illnesses.

Cytonus Therapeutics, Inc. is a biotechnology company founded in 2018 and located in Columbus, Ohio. The company specializes in developing immune-oncology and gene therapies aimed at addressing devastating and rare diseases. Cytonus employs a synthetic biology approach through its proprietary Cargocyte technology, which enables precision delivery of therapeutics and in vivo production of innovative treatments. By integrating AI-driven drug discovery methods, Cytonus is focused on creating first-in-class therapeutics to treat immune-related disorders effectively.

Quad Miners is a cybersecurity software developer focused on addressing security threats and enhancing internet security. The company employs a machine learning-based artificial intelligence analysis engine that enables the storage of network traffic without data loss while effectively detecting threats and anomalies. By leveraging this advanced technology, Quad Miners provides customers with reliable solutions to safeguard their data against malware attacks, ensuring easy and accurate cyber defense.

CONTEC is providing ground station services, satellite image processing, and application services. The company's ground station network supports VHF, UHF, S-Band, and X-Band frequencies for TT&C via high-performance receivers for high data rate reception. They especially focus on applications for urban change detection of smart cities and aim to provide the best service possible for local governments and therefore contribute to urban development. Contec's main goal of building a global ground station network and operating its own Earth observation satellites.

Rznomics is a biotechnology company founded by Professor Lee Sung-wook's lab, specializing in the development of ribonucleic acid-based gene therapies. The company focuses on creating innovative biopharmaceuticals aimed at addressing significant medical challenges, particularly in the treatment of liver cancer, various cancers, degenerative neurological diseases, and hereditary disorders. Rznomics has been recognized for its technological advancements and was selected by the TIPS program, highlighting its commitment to addressing medical needs that remain unmet in current healthcare. Through its research and development efforts, Rznomics aims to enable medical practitioners to effectively treat complex conditions such as cancer and Alzheimer's disease.

FastView is a company that specializes in content commerce and online marketing services, focusing on enhancing the production and distribution capabilities of soft content. It offers a range of services designed to support creators in developing and expanding their content businesses, including content marketing and online auto agency services. By providing these tailored marketing solutions, FastView aims to improve the overall effectiveness of content creators in reaching their target audiences and achieving their business goals.

Witchcraft operates as a marketplace for crafting ideas into digital assets. It offers a secure platform for storing these digital assets indefinitely. The company's services extend to the realms of online auctions, online portals, and virtual reality. Witchcraft also provides a user-friendly and transparent blockchain wallet, known as Witch Wallet. This wallet ensures the ownership of digital assets through its 'Craft'ing feature.

StoreLink operates as an optimization platform for online marketplaces. It leverages AI-driven tools and accurate sales data analysis to enhance product visibility and improve sales forecasts, thereby boosting revenues for its client sellers.

Bastera is a biotech company with the primary goal of developing groundbreaking treatments for cardiovascular and cancer diseases. Their approach involves targeting new redox signaling pathways, aiming to pioneer "first-in-class" therapies in these fields. Vastera was established in 2018 when SangWon Kang, a professor at Ewha Womans University, transferred a patent based on research results on redox signaling in blood vessels and cancer.

Astrogen is a biotechnology company focused on developing innovative drugs to address intractable neurological diseases. The company conducts clinical research aimed at creating treatment alternatives for conditions such as autism spectrum disorder and Alzheimer's disease. By concentrating on drug development, Astrogen seeks to provide medical professionals with effective options for managing and potentially curing patients afflicted with challenging neurological disorders.

AmazeVR is a virtual concert platform that specializes in the creation and distribution of immersive music content using proprietary technologies. Founded in 2015 by former executives of a prominent mobile platform company, AmazeVR offers an end-to-end solution that transforms the concert experience through ultra-high-resolution custom cameras, cloud-based creation tools, and interactive social features that allow fans to engage as avatars. The platform enables artists to connect more closely with their audiences by facilitating both online and offline concert experiences, adhering to safety measures. Through its innovative approach, AmazeVR aims to redefine how music fans experience live performances, making them more accessible and engaging.

Lysentech is a biotechnology company focused on developing novel treatments for antibiotic-resistant bacteria. The company's primary expertise lies in utilizing bacteriophages and phage-derived endolysins to create effective antibiotics. Additionally, Lysentech is advancing the development of oncolytic bacteriophages that specifically target cancer cells, providing a potential new approach for delivering anticancer therapies. By harnessing the unique properties of bacteriophages, Lysentech aims to address critical healthcare challenges posed by antibiotic resistance and improve cancer treatment outcomes.

Allo is a developer of a visual workspace platform that aims to improve collaboration among internal teams and external partners. The platform is designed to adapt to various workflows, facilitating activities such as brainstorming, project management, and team alignment. By leveraging technology, Allo offers a unique collaboration experience that includes web-based invitations and integrates with other applications, enhancing communication and teamwork. This focus on adaptability and integration allows organizations to streamline their collaborative efforts and achieve their goals more effectively.

OGQ is a developer of a social creator platform that facilitates connections between creators and their fans, allowing creators to sell their works directly. The platform hosts a diverse array of content, including images, videos, music, stickers, illustrations, and graphics in various formats, such as PSD and AI. With over 14 million creators, including photographers, musicians, and illustrators, OGQ serves a global audience, with significant user bases in the United States, India, and Russia. The platform has achieved substantial popularity, boasting 240 million app downloads and 2.6 billion content downloads, while maintaining a high user rating of 4.6 on Google Play. OGQ supports content in 30 languages, providing users with high-definition materials for various applications, including messaging services and search platforms.

OKXE is an online marketplace specializing in the buying and selling of motorcycles. The company connects motorcycle sellers and buyers through its e-commerce platform, which leverages artificial intelligence and big data to enhance the shopping experience. OKXE features a diverse selection of motorcycles from various brands and stores, ensuring that all listings are verified for quality and authenticity. This commitment to safety and transparency allows customers to engage in a streamlined and secure online motorbike shopping experience.

Cerecin is a healthcare company based in Denver, Colorado, founded in 2001, that specializes in developing novel therapeutics and products aimed at addressing neurological conditions. The company focuses on conditions such as memory impairment and Alzheimer’s disease, creating evidence-based solutions that include pharmaceuticals, medical foods, diagnostics, medical devices, and e-health products. Employing lipid science, Cerecin explores the therapeutic potential of medium-chain triglycerides, which are intended to induce ketosis and enhance mitochondrial metabolism. By providing clinicians with innovative brain health-focused products and therapies, Cerecin seeks to improve the lives of millions affected by neurodegenerative diseases.

IMBiologics is a biotechnology company focused on developing innovative immunomodulatory antibody drugs aimed at restoring physiological balance. The company specializes in creating novel treatment options for autoimmune diseases and cancer. Its offerings include antibody-based immune modulating biologics that leverage advanced mechanisms of action to modulate the immune system. By utilizing modern biotechnological techniques, IMBiologics enables new approaches to cancer treatment, positioning itself as a key player in the field of immunotherapy.

Upstairs is an online platform or B2B marketplace for customers to buy or sell previously used and owned mobile phones.

Ring Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative gene therapies utilizing its proprietary Anellovector platform. This platform, based on the human commensal virome, addresses several limitations of existing gene therapies, including restricted access to diverse tissues, challenges in redosing, risks of genomic integration, and issues with tolerability. Founded in 2017 and previously known as VL46, Inc., Ring Therapeutics aims to expand the applications of gene therapy beyond traditional gene replacement. By enabling a broader range of therapeutic modalities and mechanisms, the company seeks to treat a variety of previously inaccessible diseases, including genetic disorders, ophthalmology, oncology, and metabolic conditions.

Drimaes is a developer of an automotive software platform focused on enhancing in-vehicle infotainment services. The company aims to improve the driving experience by integrating innovative mobility solutions that make travel more enjoyable and comfortable. Utilizing advanced technologies, including automated grade Linux, hardware porting, and optimization tailored to micro-controller characteristics, Drimaes enables users to access enhanced smartphone application content directly on the vehicle's driving interface. The platform emphasizes improved data interfacing and interface technology, ensuring a seamless connection between users and their devices while on the road.

Senda Biosciences, founded in 2017 by David Kolesky, Ignacio Martinez, and John Casey in Cambridge, Massachusetts, focuses on developing therapeutic applications for innovative treatments of human diseases. The company specializes in studying the molecular relationships between bacterial, botanical, and human cells to understand how these interactions influence health and disease. By gaining insights into these interspecies connections, Senda Biosciences aims to create novel categories of medicines and delivery methods, providing medical professionals with new tools to combat various illnesses.

Newracle Genetics is a bio venture company that develops gene therapy products for neurological diseases.

Medipixel, Inc. is a South Korean MedTech startup founded in 2017, specializing in artificial intelligence-based diagnostic software and semi-autonomous robotic systems for lung cancer and cardiac interventions. The company is comprised of a team of AI experts in computer vision, deep learning, and reinforcement learning, collaborating with top healthcare professionals, including those at Seoul Asan Medical Center, to enhance disease diagnosis and surgical procedures. Medipixel offers three primary solutions for intervention surgeons: an AI-based diagnosis tool that assists in identifying lesions during coronary angiography, a guide and planning solution that visualizes coronary arteries to facilitate guidewire manipulation, and an automated navigation engine that directs robotic units through arteries with real-time commands. These innovations aim to improve surgical outcomes and patient safety by reducing reliance on contrast agents and enhancing the precision of interventions.

Cenyx Biotech is a pioneering company in the field of nanobiotechnology, focused on developing innovative diagnostic and therapeutic nano-compounds utilizing nanozymes and nanoparticles. The company aims to transform healthcare by creating a nano-biotech agent capable of simultaneously eliminating superoxide, hydrogen peroxide, and hydroxyl radicals. This technology is particularly relevant for addressing excessive inflammatory responses that arise during the early stages of subarachnoid hemorrhage. By leveraging these advanced nano-compounds, Cenyx Biotech seeks to provide effective solutions for patients and healthcare practitioners, ultimately enhancing treatment outcomes in critical medical conditions.

Anipen is a Korean company focused on developing 3D content and augmented reality applications tailored for short video platforms and video games. The firm utilizes advanced augmented reality and deep learning technologies to create engaging content, including AR web TV shows, promotional videos for social media, and animated clips optimized for mobile devices. By providing these innovative solutions, Anipen enables enterprises to enhance their video communication and entertainment offerings, thereby promoting their products effectively in a competitive digital landscape.

Rznomics is a biotechnology company founded by Professor Lee Sung-wook's lab, specializing in the development of ribonucleic acid-based gene therapies. The company focuses on creating innovative biopharmaceuticals aimed at addressing significant medical challenges, particularly in the treatment of liver cancer, various cancers, degenerative neurological diseases, and hereditary disorders. Rznomics has been recognized for its technological advancements and was selected by the TIPS program, highlighting its commitment to addressing medical needs that remain unmet in current healthcare. Through its research and development efforts, Rznomics aims to enable medical practitioners to effectively treat complex conditions such as cancer and Alzheimer's disease.

AmazeVR is a virtual concert platform that specializes in the creation and distribution of immersive music content using proprietary technologies. Founded in 2015 by former executives of a prominent mobile platform company, AmazeVR offers an end-to-end solution that transforms the concert experience through ultra-high-resolution custom cameras, cloud-based creation tools, and interactive social features that allow fans to engage as avatars. The platform enables artists to connect more closely with their audiences by facilitating both online and offline concert experiences, adhering to safety measures. Through its innovative approach, AmazeVR aims to redefine how music fans experience live performances, making them more accessible and engaging.

AffaMed Therapeutics is a biopharmaceutical company dedicated to developing and commercializing innovative pharmaceutical products. The company focuses on accelerating the clinical development of new therapies aimed at addressing significant unmet medical needs, particularly in the fields of ophthalmology, neurology, and psychiatry. By targeting these critical areas, AffaMed strives to create impactful solutions that improve the lives of patients globally.

Astrogen is a biotechnology company focused on developing innovative drugs to address intractable neurological diseases. The company conducts clinical research aimed at creating treatment alternatives for conditions such as autism spectrum disorder and Alzheimer's disease. By concentrating on drug development, Astrogen seeks to provide medical professionals with effective options for managing and potentially curing patients afflicted with challenging neurological disorders.

EJN Corp. is an IT company based in Seoul, South Korea, specializing in online community platforms and services tailored for gamers. Established in 2016, the company operates several key platforms, including Battle.dog, an e-sports platform that analyzes viewing data from competitions, and Twip, an online sales channel designed for creators and streamers. Additionally, EJN provides community and payment services for game video streaming, enhancing the overall experience for both gamers and content creators. Through its innovative offerings, EJN aims to foster engagement and support within the gaming community.

Chatie is a technology company specializing in the development of a unique story-writing application. This platform allows users to create and share stories in various formats, including romantic, horror, and fanfiction genres. The application supports multiple media types such as text, video, photos, and sound, along with optional endings, making it accessible and engaging for both writers and readers.

Checkmate Therapeutics is a biotech company that discovers and develops novel approaches for cancer immunotherapy such as immuno-oncology.

Linewalks is a data technology company focused on the healthcare sector. It specializes in developing advanced data analysis tools that harness the power of big data to derive valuable insights. Utilizing artificial intelligence, Linewalks analyzes real-world data generated in clinical settings to identify clinical evidence and monitor the treatment pathways of patients, particularly those with cardiovascular diseases. This innovative approach enables pharmaceutical companies and hospitals to uncover critical insights about patient care, assess individual risk factors, and ultimately enhance the efficiency of healthcare delivery. By leveraging comprehensive data analytics, Linewalks aims to facilitate informed decision-making in the healthcare industry.

EvidNet is a healthcare IT company focused on providing Real World Evidence (RWE) solutions that leverage hospital data to enhance research and decision-making in the life sciences and healthcare sectors. The company collaborates with over 50 university and tertiary hospitals in Korea to generate Real World Data (RWD) using the OMOP-CDM standard. Its FeederNet® data platform facilitates multi-institutional research and allows for AI-driven federated machine learning, ensuring privacy and security are maintained. EvidNet's platform is designed to support precision and predictive medicine by creating an interoperable, real-time healthcare data network. This network offers tailored statistical analysis to meet the specific needs of hospitals and healthcare providers, enabling easier access to vital health information for both professionals and patients.

Bagelcode, Inc. is a mobile gaming company based in Seoul, South Korea, founded in 2012. It specializes in developing mobile social casino games, allowing users to engage in popular casino experiences such as slots and poker on web and mobile platforms. The company has a diverse workforce of over 170 members from various countries, including the United States, Canada, and Israel, fostering a global talent pool to enhance its gaming offerings. With a user base exceeding 45 million worldwide, Bagelcode has experienced significant growth, reportedly expanding at an average rate of over 250% in recent years. The company is committed to continuous innovation and seeks to position itself as a leader in the global gaming industry by attracting top talent and enhancing user experiences.

Astrogen is a biotechnology company focused on developing innovative drugs to address intractable neurological diseases. The company conducts clinical research aimed at creating treatment alternatives for conditions such as autism spectrum disorder and Alzheimer's disease. By concentrating on drug development, Astrogen seeks to provide medical professionals with effective options for managing and potentially curing patients afflicted with challenging neurological disorders.

Hidden Sequence is a production company specializing in drama content creation. It operates by producing and financing stage dramas, films, and television shows based on original scripts, featuring local talent. The company aims to cater to diverse artistic tastes through its varied offerings.

OKXE is an online marketplace specializing in the buying and selling of motorcycles. The company connects motorcycle sellers and buyers through its e-commerce platform, which leverages artificial intelligence and big data to enhance the shopping experience. OKXE features a diverse selection of motorcycles from various brands and stores, ensuring that all listings are verified for quality and authenticity. This commitment to safety and transparency allows customers to engage in a streamlined and secure online motorbike shopping experience.

Radish is a mobile fiction platform that specializes in serialized storytelling, offering readers a diverse array of stories presented in bite-sized installments tailored for smartphone use. The platform allows readers to explore thousands of serials across multiple genres, including romance, fantasy, young adult, paranormal, mystery, and science fiction. Radish fosters direct interaction between readers and authors through live community chat rooms, enhancing the reader experience. For writers, Radish provides a unique opportunity to publish original works, revive previously published titles, and generate anticipation for upcoming stories, all while ensuring they receive immediate compensation and retain copyright ownership. This innovative approach is transforming the landscape of story consumption and production.

Z-emotion is a South Korea-based company specializing in 3D garment simulation technology, aimed at advancing the digital transformation of the fashion industry. Its flagship product, z-weave, is a 3D CAD software that allows apparel businesses and professionals to visualize their fashion concepts effectively. The platform offers a range of features, including predictive analytics, virtual showrooms, custom animations, bespoke avatars, and auto stitching, all designed to facilitate informed decision-making in garment design. In addition to its headquarters in South Korea, Z-emotion operates offices in Hong Kong and the USA, with virtual teams located across Europe. The company has attracted notable strategic investors, including LG Electronics, NAVER, HTC, and Shima Seiki, further validating its innovative approach in the apparel sector.

GeneCast is a biotechnology company specializing in advanced cancer diagnostics. It develops proprietary technology that selectively amplifies mutated genes, enabling early detection and monitoring of cancer via liquid biopsy. This approach allows for faster, more accurate diagnosis and tailored treatment plans for patients.

Ubix Therapeutics, Inc. is a research and development company based in Seoul, South Korea, focused on the development of anti-cancer drugs utilizing a proprietary proteolysis targeting chimera platform. The company employs advanced inhibitor technology that degrades specific target proteins within cells, aiming to enhance therapeutic efficacy for various cancers. By binding to proteins associated with disease, Ubix Therapeutics seeks to provide life-saving medications for patients, thereby supporting both patients and medical professionals in the fight against cancer.

Positive Hotel is a company focused on promoting sustainable wellness through a range of products. It specializes in Mediterranean diet offerings, including food ingredients, wellness blends, olive capsules, and collagen supplements. By providing convenient and health-oriented products, Positive Hotel aims to help customers adopt healthier eating habits and enhance their overall well-being. The brand embodies an urban lifestyle approach, catering to individuals seeking to integrate wellness into their daily lives.

Phantom AI, Inc. is a technology company based in Burlingame, California, focused on developing advanced driver-assistance systems (ADAS) for autonomous vehicles. Founded in 2016, the company offers a range of innovative solutions, including PhantomVision, a deep learning-based computer vision system that supports the detection of vehicles, pedestrians, cyclists, and traffic signals. Additionally, Phantom AI provides PhantomFusion, a sensor fusion platform that integrates data from various sensors like cameras, radar, LiDAR, and ultrasonic devices to create a comprehensive environmental model. The company also features PhantomDrive, a vehicle control solution that ensures safe and natural vehicle movement by accurately predicting the motion of detected objects. By delivering high-performance AI solutions at a competitive price, Phantom AI aims to democratize access to ADAS technology, ultimately enhancing safety and driving enjoyment while laying the groundwork for future self-driving capabilities.

AmazeVR is a virtual concert platform that specializes in the creation and distribution of immersive music content using proprietary technologies. Founded in 2015 by former executives of a prominent mobile platform company, AmazeVR offers an end-to-end solution that transforms the concert experience through ultra-high-resolution custom cameras, cloud-based creation tools, and interactive social features that allow fans to engage as avatars. The platform enables artists to connect more closely with their audiences by facilitating both online and offline concert experiences, adhering to safety measures. Through its innovative approach, AmazeVR aims to redefine how music fans experience live performances, making them more accessible and engaging.

Olive Healthcare is a company specializing in digital healthcare and medical diagnostic devices. It focuses on abdominal fat scanning and breast cancer diagnosis by utilizing non-radiative and non-invasive near infrared (NIR) technology. The company employs artificial intelligence algorithms and big data processing to deliver customized medical services. Olive Healthcare's devices not only measure abdominal fat but also offer personalized exercise and diet guidance based on individual health metrics. By providing these tailored services, the company aims to assist users in reducing belly fat and mitigating the risk of metabolic diseases.

Cellestia Biotech AG is a biopharmaceutical company based in Basel, Switzerland, specializing in the development of innovative anti-cancer therapies. Founded in 2014 as a spin-off from EPFL in Lausanne, Cellestia focuses on its lead candidate, CB-103, an oral pan-NOTCH inhibitor designed to treat NOTCH-dependent leukemia, lymphoma, and solid tumors. The company is committed to advancing its research and development pipeline, which includes novel transcription factor inhibitors for oncology, autoimmune, and inflammatory disorders. Cellestia aims to enhance patient outcomes by developing NOTCH-specific biomarkers and diagnostics for more effective patient selection. With its emphasis on modulating pathogenic gene expression through selective inhibition of transcription factors, Cellestia is dedicated to pioneering breakthroughs in cancer treatment.

Rznomics is a biotechnology company founded by Professor Lee Sung-wook's lab, specializing in the development of ribonucleic acid-based gene therapies. The company focuses on creating innovative biopharmaceuticals aimed at addressing significant medical challenges, particularly in the treatment of liver cancer, various cancers, degenerative neurological diseases, and hereditary disorders. Rznomics has been recognized for its technological advancements and was selected by the TIPS program, highlighting its commitment to addressing medical needs that remain unmet in current healthcare. Through its research and development efforts, Rznomics aims to enable medical practitioners to effectively treat complex conditions such as cancer and Alzheimer's disease.

Vedanta Biosciences, Inc. is a clinical-stage microbiome company based in Cambridge, Massachusetts, focusing on the development of therapies for immune-mediated diseases. Established in 2010, the company specializes in creating immunotherapies utilizing human microbiome-derived bacteria. Its innovative platform includes a collection of defined bacterial consortia, proprietary assays for selecting effective strains, and extensive datasets from human interventional studies. Vedanta Biosciences also possesses capabilities for cGMP-compliant manufacturing, allowing for the production of live bacterial therapies in powder form. This enables healthcare providers to administer oral treatments aimed at addressing autoimmune and inflammatory diseases efficiently, potentially pioneering a new category of therapies based on the human microbiome.

Maxst Co Ltd is an augmented reality (AR) technology company that specializes in research and development to enhance physical reality through AR, artificial intelligence, and computer vision technology. The company offers a range of products, including an AR Software Development Kit (SDK), AR Collaboration tools, and AR Guide applications, all designed for security, reliability, and scalability. These products support various infrastructure, applications, devices, and hardware. Maxst has established partnerships with prominent organizations such as Hyundai, Kia, SK Telecom, LG Electronics, KT, and Naver, positioning itself as a leader in the AR market. Through its innovative solutions, Maxst aims to empower developers and organizations by providing immediate visual tools to improve decision-making capabilities.

Sharetreats Innovation is a company based in Makati, Philippines, that has developed a platform enabling consumers to send and receive vouchers redeemable at select nearby branches. After a payment is completed, treat codes are delivered via SMS, facilitating a seamless gifting experience. In addition to its voucher system, Sharetreats promotes a cultural movement encouraging social interactions through casual gifts, offering a variety of stickers and greetings suitable for various events.

Vedanta Biosciences, Inc. is a clinical-stage microbiome company based in Cambridge, Massachusetts, focusing on the development of therapies for immune-mediated diseases. Established in 2010, the company specializes in creating immunotherapies utilizing human microbiome-derived bacteria. Its innovative platform includes a collection of defined bacterial consortia, proprietary assays for selecting effective strains, and extensive datasets from human interventional studies. Vedanta Biosciences also possesses capabilities for cGMP-compliant manufacturing, allowing for the production of live bacterial therapies in powder form. This enables healthcare providers to administer oral treatments aimed at addressing autoimmune and inflammatory diseases efficiently, potentially pioneering a new category of therapies based on the human microbiome.

Z-emotion is a South Korea-based company specializing in 3D garment simulation technology, aimed at advancing the digital transformation of the fashion industry. Its flagship product, z-weave, is a 3D CAD software that allows apparel businesses and professionals to visualize their fashion concepts effectively. The platform offers a range of features, including predictive analytics, virtual showrooms, custom animations, bespoke avatars, and auto stitching, all designed to facilitate informed decision-making in garment design. In addition to its headquarters in South Korea, Z-emotion operates offices in Hong Kong and the USA, with virtual teams located across Europe. The company has attracted notable strategic investors, including LG Electronics, NAVER, HTC, and Shima Seiki, further validating its innovative approach in the apparel sector.

Bagelcode, Inc. is a mobile gaming company based in Seoul, South Korea, founded in 2012. It specializes in developing mobile social casino games, allowing users to engage in popular casino experiences such as slots and poker on web and mobile platforms. The company has a diverse workforce of over 170 members from various countries, including the United States, Canada, and Israel, fostering a global talent pool to enhance its gaming offerings. With a user base exceeding 45 million worldwide, Bagelcode has experienced significant growth, reportedly expanding at an average rate of over 250% in recent years. The company is committed to continuous innovation and seeks to position itself as a leader in the global gaming industry by attracting top talent and enhancing user experiences.

Riiid is a global innovator in AI-powered education solutions, specializing in adaptive assessment platforms that personalize learning experiences for students worldwide. Launched in 2017 with Santa TOEIC, its flagship product has reached over one million users in Korea alone, demonstrating proven efficacy. Expanding globally, Riiid operates Santa TOEIC in Japan and offers Santa SAT in Vietnam. Its scalable AI technology provides each student with a personalized tutor, enhancing learning outcomes while reducing costs compared to traditional methods. By democratizing educational opportunities, Riiid is rapidly transforming the learning landscape.

Infit & Company Inc. is a manufacturer of medical diagnostic devices and wellness devices that targeting global healthcare industry.

GeneCast is a biotechnology company specializing in advanced cancer diagnostics. It develops proprietary technology that selectively amplifies mutated genes, enabling early detection and monitoring of cancer via liquid biopsy. This approach allows for faster, more accurate diagnosis and tailored treatment plans for patients.

Olive Healthcare is a company specializing in digital healthcare and medical diagnostic devices. It focuses on abdominal fat scanning and breast cancer diagnosis by utilizing non-radiative and non-invasive near infrared (NIR) technology. The company employs artificial intelligence algorithms and big data processing to deliver customized medical services. Olive Healthcare's devices not only measure abdominal fat but also offer personalized exercise and diet guidance based on individual health metrics. By providing these tailored services, the company aims to assist users in reducing belly fat and mitigating the risk of metabolic diseases.

J2H Biotech is a bio-venture company dedicated to the development of small-molecule drugs aimed at treating rare and intractable diseases. The company specializes in creating synthetic medications that enhance oral absorption rates and employs patented systems to facilitate the availability of generic drugs for conditions such as rare diseases, infectious diseases, and liver diseases. By focusing on these innovative approaches, J2H Biotech seeks to provide healthcare professionals with differentiated therapeutic options that can improve patient outcomes and contribute to overall public health.

Bionetix Therapeutics is a developer of anticancer drugs designed for cancer treatment. The company's drugs include medicines for ophthalmic disease and glaucoma treatment, enabling patients to get early treatment for eye diseases, cancer and other diseases with unmet needs.

PinotBio, Inc., formerly known as Bionetix, Inc., is a biotechnology company based in Suwon, South Korea, focused on researching and developing innovative small molecule drugs for the ophthalmology and oncology sectors. Established in 2017, the company is engaged in pre-clinical trials for its lead product, NTX-101, which targets glaucoma, alongside other technologies aimed at developing anticancer treatments based on epigenetics. PinotBio's drug development efforts are designed to address refractory and relapsed cancers, as well as other challenging diseases, ultimately enabling healthcare professionals to provide effective therapies for patients facing life-threatening conditions.

Moai Games is a gaming company that offers video and PC games.

MOAIGAMES is a gaming platform that offers role-playing mobile and video games.

Yanolja is a leisure platform headquartered in Seoul, South Korea, that provides a comprehensive range of online accommodation and travel services. Founded in 2005, the company connects various aspects of travel, including lodging, leisure activities, and transportation, allowing users to book diverse hotel options globally. Yanolja leverages advanced technologies such as artificial intelligence, blockchain, and IoT to enhance its offerings. In addition to consumer services, the company provides cloud-based software solutions for hotels, residences, and leisure facilities, streamlining operations and improving efficiency across the travel industry.

In the early days of E-Sports, unrivaled skills and overflowing enthusiasm towards games were the only two requisites to become a professional gamer. Nowadays with the rise of global E-Sports fandoms, performance became only one of many requisites of a pro-gamer. Fans are connected to pro-gamers everywhere through various channels such as SNS and live & video platforms. In order to satisfy their needs and be loved by them, a professional gamer needs more than just playing games. E-Sportainment is the compound word of E-Sports and Entertainment. It’s the most explicit and mission-oriented word to describe what STILL8 does. Combining entertainment factors with E-Sports, we help current pro-gamers to boost their talents and retired pro-gamers to sustain their career. Playing games is one part, amusing fans with various entertainments is another. As so, STILL8 ultimately pursues the E-Sports of the gamer, by the gamer, and for the gamer.

MyMusicTaste is a crowdsourcing platform dedicated to organizing live music events, specifically concerts and music festivals. It connects fans, artists, and promoters, allowing fans to request performances from their favorite artists in their local areas. By leveraging data-driven insights, MyMusicTaste empowers artists and concert promoters to effectively plan and execute successful events based on fan demand. This innovative approach facilitates a more interactive concert experience and enables a new model for organizing live events, making it easier for fans to influence the music landscape and connect with the artists they love.

In the early days of E-Sports, unrivaled skills and overflowing enthusiasm towards games were the only two requisites to become a professional gamer. Nowadays with the rise of global E-Sports fandoms, performance became only one of many requisites of a pro-gamer. Fans are connected to pro-gamers everywhere through various channels such as SNS and live & video platforms. In order to satisfy their needs and be loved by them, a professional gamer needs more than just playing games. E-Sportainment is the compound word of E-Sports and Entertainment. It’s the most explicit and mission-oriented word to describe what STILL8 does. Combining entertainment factors with E-Sports, we help current pro-gamers to boost their talents and retired pro-gamers to sustain their career. Playing games is one part, amusing fans with various entertainments is another. As so, STILL8 ultimately pursues the E-Sports of the gamer, by the gamer, and for the gamer.

Likely is an online store for women's fashion.